THE INFLUENCE OF SODIUM ORTHOVANADATE ON P85 AND GSK-3 EXPRESSIONS TO THE BLOOD GLUCOSE REGULATION OF TYPE 2 DIABETIC MICE (MUS MUSCULUS) MODEL
Keywords:
Sodium orthovanadate, Diabetes mellitus, P85 (Regulatory Subunit of PI3-Kinase), GSK-3 (Glycogen Synthase Kinase 3)Abstract
Objective: The present study was designed to investigate the influence of sodium orthovanadate on the P85 (Regulatory Subunit of PI3-Kinase) and GSK-3 (Glycogen Synthase Kinase 3) expressions in skeletal muscle tissue to the decreasing of blood glucose levels of alloxan-induced diabetic mice.
Methods: Mice were divided into 5 groups i. e. (1) naive group, (2) diabetic group and (3-5) orthovanadate-treated diabetic groups at the dose of 16, 32 and 64 mg/kg BW respectively. Diabetic mice model was induced by intraperitoneal administration of alloxan monohydrate at the dose of 200 mg/kgBW. Diabetic state was occurred on day 3 after alloxan injection and then started the treatment of sodium orthovanadate for 7 days. The muscular tissue was harvested on day 10 after treatment and was stained using routine histology staining, haematoxylin-eosin for morphological qualitative analysis and immunohistochemical approaches to observe the expressions of P85 and GSK-3 in skeletal muscle.
Results: Diabetes condition was shown by the increasing of fasting blood glucose levels from 59.1 ± 11.2 mg/dL to 310.6 ± 107.2 mg/dL on day 3. Administration of sodium orthovanadate at the dose of 16, 32 and 64 mg/kg BW reduced the fasting blood glucose levels after 7 days treatment (p < 0.001) at diabetic mice significantly. The results of histology staining showed that sodium orthovanadate improved a necrosis in skeletal muscle cells alloxan-induced diabetic mice. On immunohistochemical approaches, sodium orthovanadate might decreased the P85 expressions and increased the GSK-3 expressions in skeletal muscle cells alloxan-induced diabetic mice (p < 0.001).
Conclusion: This study reveals that the administration of sodium orthovanadate on diabetic mice led to the attenuation of the PTPase activity. The inhibition cause a decreasing the expression of P85 and increasing of GSK-3 that cause the decreasing of blood glucose levels and an improvement of insulin target cells in the muscle cells.
Â
Downloads
References
Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 2010;1(3):68-75.
Sudagani J, Hitman GA. Diabetes Mellitus: etiology and epidemiology. encyclopedia of human nutrition (third edition). London: Elsevier Inc; 2013.
Barbour LA, Rahman SM, Gurevich I, Leitner JW, Fishcer SJ, Roper MD, et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 2005;280(45):37489-94.
Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003;116(7):1175-86.
Patel S, Doble BW, MacAulay K, Sinclair EM, Drucker DJ, Woodgett JR. Tissue-specific role of glycogen synthase kinase 3β in glucose homeostasis and insulin action. Mol Cell Biol 2008;28(20):6314-28.
Vicente SG, Yraola F, Marti L, Munoz EG, Barrado MJG, Canto C, et al. Oral insulin-mimetic compounds that act independently of insulin. Diabetes 2007;56:486-93.
Arya GS, Hedaytullah MD, Raghvendra, Yadav A, Sachan K. Treating diabetes mellitus with vanadium salts-a future prospectus: a review. Int J Pharm Sci Rev Res 2011;8(2):183-5.
Jiang S, Du P, An L, Yuan G, Sun Z. Anti-diabetic effect of coptis chinensis polysaccharide in high-fat diet with STZ-induced diabetic mice. Int J Biol Macromol 2013;55:118-22.
Fawcett DW. A textbook of histology, 12th ed. USA: Chapman and Hall Inc; 2002.
Nowak M, Madej JA, Dziegiel P. Intensity of COX-2 expression in cells of soft tissue fibrosarcomas in dogs as related to grade of tumour malignancy. Bull Vet Inst Pulawy 2007;51:275-9.
O’Connor JC, Freund GG. Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. Metab 2003;52(6):666-74.
Rehder D. Biological and medicinal aspect of vanadium. Inorg Chem Commun 2003;6:604-17.
Tracey AS, Willsky GR, Takeuchi E. Vanadium: Chemistry, biochemistry, pharmacology, and practical application. New York: CRC Press; 2007.
Henriksen EJ, Dokken BB. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Curr Drug Targets 2006;7(10):1-7.